The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
Open accessAbstract
Bacterial translocation (BTL) drives pathogenesis and complications of cirrhosis. Farnesoid X-activated receptor (FXR) is a key transcription regulator in hepatic and intestinal bile metabolism. We studied potential intestinal FXR dysfunction in a rat model of cholestatic liver injury and evaluated effects of obeticholic acid (INT-747), an FXR agonist, on gut permeability, inflammation, and BTL. Rats were gavaged with INT-747 or vehicle during 10 days after bile-duct ligation and then were assessed for changes in gut permeability, BTL, and tight-junction protein expression, immune cell recruitment, and cytokine expression in ileum, mesenteric lymph nodes, and spleen. Auxiliary in vitro BTL-mimicking experiments were performed with Transwell supports. Vehicle-treated bile duct-ligated rats exhibited decreased FXR pathway expression in both jejunum and ileum, in association with increased gut permeability through increased claudin-2 expression and related to local and systemic recruitment of natural killer cells resulting in increased interferon-γ expression and BTL. After INT-747 treatment, natural killer cells and interferon-γ expression markedly decreased, in association with normalized permeability selectively in ileum (up-regulated claudin-1 and occludin) and a significant reduction in BTL. In vitro, interferon-γ induced increased Escherichia coli translocation, which remained unaffected by INT-747. In experimental cholestasis, FXR agonism improved ileal barrier function by attenuating intestinal inflammation, leading to reduced BTL and thus demonstrating a crucial protective role for FXR in the gut-liver axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, FXR activation by agonists GW4064 or obeticholic acid (OCA) attenuates mucosal injury, ileal barrier permeability, bacterial overgrowth and bacterial translocation in mice and rats 20,21,141,142.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [141]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
Moreau, R., Jalan, R., Ginès, P., Pavesi, M., Angeli, P., Córdoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.042 · Cited by 3,041
Self-citationRole of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931
Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 2×
“FXR deficiency has therefore been linked to increased intestinal permeability and BTL in noneliver-related gastrointestinal disorders, such as inflammatory bowel disease.(25,26) However, whether FXR dysfunction also relates to BTL in chronic liver disease (and also what are the underlying pathophysiological mechanisms…”
BackgroundResultTight Junction Pore and Leak Pathways: A Dynamic Duo
Shen, L., Weber, C. R., Raleigh, D. R., Yu, D., & Turner, J. R. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142150 · Cited by 867
Berg, R. D., & Garlington, A. W. (1979) · Infection and Immunity · doi:10.1128/iai.23.2.403-411.1979 · Cited by 845
Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.
Madara, J. L., & Stafford, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113938 · Cited by 758
Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
Wang, F., Graham, W. V., Wang, Y., Witkowski, E. D., Schwarz, B. T., & Turner, J. R. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62264-x · Cited by 692
Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639
Vanuytsel, T., van Wanrooy, S., Vanheel, H., Vanormelingen, C., Verschueren, S., Houben, E., Salim Rasoel, S., Tόth, J., Holvoet, L., Farré, R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305690 · Cited by 615
Self-citationBacterial translocation of enteric organisms in patients with cirrhosis
Cirera, I., Bauer, T., Navasa, M., Vilà, J., Grande, L., Taurá, P., Fuster, J., García‐Valdecasas, J. C., Lacy, A. M., Suárez, M. J., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00013-1 · Cited by 429
Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia
Vanheel, H., Vicario, M., Vanuytsel, T., Van Oudenhove, L., Martinez, C., Keita, Å. V., Pardon, N., Santos, J., Söderholm, J. D., Tack, J., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303857 · Cited by 424
Self-citationA Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis
Altamirano, J., Miquel, R., Katoonizadeh, A., Abraldeṣ, J. G., Duarte‐Rojo, A., Louvet, A., Augustín, S., Mookerjee, R. P., Michelena, J., Smyrk, T. C., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.018 · Cited by 421
Self-citationSpontaneous bacterial peritonitis: recent guidelines and beyond
Wiest, R., Krag, A. A., & Gerbes, A. (2011) · Gut · doi:10.1136/gutjnl-2011-300779 · Cited by 384
Bruewer, M., Utech, M., Ivanov, A. I., Hopkins, A. M., Parkos, C. A., & Nusrat, A. (2005) · The FASEB Journal · doi:10.1096/fj.04-3260com · Cited by 364
Reiberger, T., Ferlitsch, A., Payer, B. A., Mandorfer, M., Heinisch, B. B., Hayden, H., Lammert, F., Trauner, M. A., Peck‐Radosavljevic, M., & Vogelsang, H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.011 · Cited by 328
Modica, S., Petruzzelli, M., Bellafante, E., Murzilli, S., Salvatore, L., Celli, N., Di Tullio, G., Palasciano, G., Moustafa, T., Halilbasic, E., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.028 · Cited by 275
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Adorini, L., Pruzanski, M., & Shapiro, D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.012 · Cited by 259
Navasa, M., Follo, A., Llovet, J., Clemente, G., Vargas, V, Rimola, A., Marco, F., Guarner, C., Forne, M., Planas, R., et al. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70069-0 · Cited by 258
Verbeke, L., Farre, R., Trebicka, J., Komuta, M., Roskams, T., Klein, S., Elst, I. V., Windmolders, P., Vanuytsel, T., Nevens, F., et al. (2014) · Hepatology · doi:10.1002/hep.26939 · Cited by 258
Self-citationEarly features of acute-on-chronic alcoholic liver failure: a prospective cohort study
Katoonizadeh, A., Laleman, W., Verslype, C., Wilmer, A. P., Maleux, G. A., Roskams, T., & Nevens, F. (2010) · Gut · doi:10.1136/gut.2009.189639 · Cited by 252
Self-citationBacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites
García–Tsao, G., Lee, F., Barden, G. E., Cartun, R. W., & West, A. B. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90147-7 · Cited by 247
Bile acid-induced negative feedback regulation of the human ileal bile acid transporter
Neimark, E., Chen, F., Li, X., & Shneider, B. L. (2004) · Hepatology · doi:10.1002/hep.20295 · Cited by 234
Poupon, R. Y. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/s2210-7401(12)70015-3 · Cited by 230
McMahan, R. H., Wang, X. X., Cheng, L. L., Krisko, T., Smith, M., El Kasmi, K., Pruzanski, M., Adorini, L., Golden-Mason, L., Levi, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.446575 · Cited by 225
Bellot, P., Garc´ıa-Paga´n, J. C., France´s, R., Abraldes, J. G., Navasa, M., Pe´rez-Mateo, M., Such, J., & Bosch, J. (2010) · Hepatology · doi:10.1002/hep.23918 · Cited by 219
Genome‐wide tissue‐specific farnesoid X receptor binding in mouse liver and intestine†
Thomas, A., Hart, S. N., Kong, B., Fang, J., Zhong, X., & Guo, G. L. (2009) · Hepatology · doi:10.1002/hep.23450 · Cited by 205
du Plessis, J., Vanheel, H., Janssen, C., Roos, L., Slavík, T., Stivaktas, P. I., Nieuwoudt, M., van Wyk, S. G., Vieira, W. A., Pretorius, E., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.038 · Cited by 178
Self-citationMencarelli, A., Renga, B., Migliorati, M., Cipriani, S., Distrutti, E., Santucci, L., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901347 · Cited by 177 · cited 1×
“anti-inflammatory response with, in particular, a remarkable decrease in the number of NKCs, both locally in the MLNs and systemically in the spleen, consistent with findings by others on the hepatic level.(50) As a logical consequence, IFN-g levels (in parallel with the decreased number of NKCs in the INT-747etreated…”
ResultClark, E. C., Hoare, C. J., Tanianis-Hughes, J., Carlson, G., & Warhurst, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.046 · Cited by 171
Watson, C. J. E., Hoare, C. J., Garrod, D. R., Carlson, G., & Warhurst, G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02630 · Cited by 171
Fickert, P., Fuchsbichler, A., Moustafa, T., Wagner, M., Zollner, G., Halilbasic, E., Stöger, U., Arrese, M., Pizarro, M., Solís, N., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090114 · Cited by 169
Bacterial Translocation in Acute and Chronic Portal Hypertension
Quigley, E. M. M., & García–Tsao, G. (1994) · Hepatology · doi:10.1002/hep.1840200145 · Cited by 165
Ariza, X., Castellote, J., Lora-Tamayo, J., Girbau, A., Salord, S., Rota, R., Ariza, J., & Xiol, X. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.010 · Cited by 154
Bacterial translocation in acute and chronic portal hypertension
García–Tsao, G., Albillos, A., Barden, G. E., & West, B. A. (1993) · Hepatology · doi:10.1002/hep.1840170622 · Cited by 141
Intestinal permeability is increased in patients with advanced cirrhosis.
Pascual, S., Such, J. M., Esteban, A., Zapater, P., Casellas, J. A., Aparicio, J. R., Girona, E., Gutiérrez, A., Carnices, F., Palazón, J. M., et al. (2003) · PubMed · Cited by 137
Llovet, J. M., Bartolí, R., Planas, R., Cabré, E., Jiménez, M., Urban, A., Ojanguren, I., Arnal, J., & Gassull, M. À. (1994) · Gut · doi:10.1136/gut.35.11.1648 · Cited by 135
FXR-mediated regulation of eNOS expression in vascular endothelial cells
Jiang, L., Wilson, A. S., Kuruba, R., Zhang, Q., Gao, X., He, F., Zhang, L., Pitt, B. R., Xie, W., & Song, L. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm016 · Cited by 127
Umgelter, A., Reindl, W., Miedaner, M., Schmid, R. M., & Huber, W. (2009) · Infection · doi:10.1007/s15010-008-8060-9 · Cited by 121
Wallon, C., Braaf, Y., Wolving, M., Olaison, G., & Söderholm, J. D. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510012235 · Cited by 97
Laleman, W., Verbeke, L., Meersseman, P., Wauters, J., van Pelt, J. F., Cassiman, D. M., Wilmer, A. P., Verslype, C., & Nevens, F. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.47 · Cited by 97
Self-citationVanwijngaerden, Y.-M., Wauters, J., Langouche, L., Perre, S. V., Liddle, C., Coulter, S., Vanderborght, S., Roskams, T., Wilmer, A. P., den Berghe, G. V., et al. (2011) · Hepatology · doi:10.1002/hep.24582 · Cited by 96
Self-citationZuckerman, M. J., Menzies, I. S., Ho, H., Gregory, G. G., Casner, N. A., Crane, R., & Hernandez, J. A. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000026307.56909.21 · Cited by 79
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited
Laleman, W., Elst, I. V., Zeegers, M., Servaes, R., Libbrecht, L. J., Roskams, T., Fevery, J., & Nevens, F. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01620.x · Cited by 77
Self-citationObstructive jaundice promotes bacterial translocation in humans.
Ma, K., It, K., Çöl, C., Tekelı, A., Tanık, A., & Köksoy, C. (1999) · PubMed · Cited by 67
Verbeke, L., Nevens, F., & Laleman, W. (2011) · Critical Care · doi:10.1186/cc10424 · Cited by 51
Self-citationChatterjee, S., Bijsmans, I. T. G. W., van Mil, S. W. C., Augustijns, P., & Annaert, P. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.10.020 · Cited by 44
Self-citationThalheimer, U., Iorio, F. D., Capra, F., Lleò, M. D. M., Zuliani, V., Ghidini, V., Tafi, M. C., Caburlotto, G., Gennari, M., Burroughs, A. K., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32833b4b03 · Cited by 43
Smyth, D. R., McKay, C. M., Gulbransen, B. D., Phan, V., Wang, A., & McKay, D. M. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01796.x · Cited by 29
Vanwijngaerden, Y.-M., Langouche, L., Derde, S., Liddle, C., Coulter, S., den Berghe, G. V., & Mesotten, D. (2013) · Shock · doi:10.1097/shk.0000000000000046 · Cited by 16
Intestinal permeability assessed by 51Cr-EDTA in rats with CCl4 - induced cirrhosis
Ramos, A. R. L., Matte, Ú. D. S., Goldani, H. A. S., de Oliveira, O. L. M., Vieira, S. M. G., & da Silveira, T. R. (2010) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032010000200014 · Cited by 9
Ubeda, M., Borrero, M. J., Lario, M., Muñoz, L., Conde, E. D. V., Rodríguez, M., Lledó, L., García-Bermejo, L., Álvarez-Mon, M., & Albillos, A. (2014) · Journal of Hepatology · doi:10.1016/s0168-8278(14)60155-0 · Cited by 5
Cited by
Sorted by citations
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
Mouries, J., Brescia, P., Silvestri, A., Spadoni, I., Sorribas, M., Wiest, R., Mileti, E., Galbiati, M., Invernizzi, P., Adorini, L., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.005 · Cited by 688
The gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
Metadata
- Authors
- Verbeke, L., Farre, R., Verbinnen, B., Covens, K., Vanuytsel, T., Verhaegen, J., Komuta, M., Roskams, T., Chatterjee, S., Annaert, P., Elst, I. V., Windmolders, P., Trebicka, J., Nevens, F., & Laleman, W.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Thomas More Kempen (BE)
- KU Leuven (BE)
- University of Bonn (DE)
- Corresponding author
- Verbeke, Len
- ORCID
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 185
- Issue
- 2
- Pages
- 409-419
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2104582722
- Cited by
- 225
- References
- 54
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 24 · 2023: 11 · 2022: 21 · 2021: 28 · 2020: 18 · 2019: 22 · 2018: 13 · 2017: 18 · 2016: 16 · 2015: 8
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- American Journal Of Pathology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Funders
- Scientific Research–Flanders
- Deutsche Forschungsgemeinschaft (SFB TRR57 project 18)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- obeticholic acid, FXR agonists, bacterial translocation, intestinal barrier dysfunction, cholestasis, bile duct ligation, intestinal permeability, claudin-2, claudin-1, occludin, tight junction proteins, natural killer cells, interferon-gamma, intestinal inflammation, gut-liver axis, liver cirrhosis, Escherichia coli
- MeSH terms
- Receptor, Farnesoid X-Activated, Animals, Chenodeoxycholic Acid, Cholestasis, Escherichia coli, Gene Expression Regulation, Ileum, Male, Cytokines, Rats, Wistar, Receptors, Cytoplasmic and Nuclear, Bacterial Translocation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
